Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00592774 · ClinicalTrials.gov registry record · Phase 2

Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)

A Phase 2 study of Neuralgia, sponsored by Eisai.

Completed
Registry status
Phase 2
Development phase
146
Enrollment target
20
Study locations

NCT00592774 is a Phase 2 study of Neuralgia that has completed, run by Eisai. The registered enrollment target is 146 participants, above the 69-participant average among 5 other Neuralgia trials with a reported enrollment target (112% higher). The trial reports 20 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00592774, a Phase 2 study of Neuralgia, has completed, sponsored by Eisai.

COMPLETED
Registry status
Phase 2
Development phase
146 participants
Enrollment target
20
Study locations

Study Summary

The purpose of the study is to determine the efficacy and safety of Perampanel (E2007) in patients with Post-Herpetic Neuralgia (PHN).

Conditions Studied

Neuralgia

Interventions

  • DRUG Placebo
  • DRUG E2007 (perampanel)

Study Locations (20)

Florida

  • - Boca Raton
  • - Bradenton
  • - Daytona Beach
  • - Delray Beach
  • - Fort Lauderdale
  • - Fort Myers
  • - Kissimmee
  • - Largo
  • - Miami
  • - Naples

California

  • - Los Angeles
  • - Sacramento
  • - San Diego
  • - San Francisco

Arizona

  • - Peoria
  • - Tucson

Colorado

  • - Boulder
  • - Denver

Arkansas

  • - Little Rock

Connecticut

  • - Milford

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2008-01
Est. Completion 2009-03
Phase Phase 2

Sponsor

Eisai

287 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00592774

The ClinicalTrials.gov registry entry for NCT00592774 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 69-participant average among 5 other Neuralgia trials with a reported enrollment target (112% higher). The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neuralgia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00592774 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Florida, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT00592774 about?

NCT00592774 is a clinical study titled "Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)". The purpose of the study is to determine the efficacy and safety of Perampanel (E2007) in patients with Post-Herpetic Neuralgia (PHN).

What is the current status of trial NCT00592774?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 146 participants. The study started on 2008-01. Estimated completion is 2009-03.

What conditions does trial NCT00592774 study?

This clinical trial studies the following conditions: Neuralgia.

What interventions are being tested in trial NCT00592774?

The interventions under investigation include: Placebo (DRUG), E2007 (perampanel) (DRUG).

Who is sponsoring clinical trial NCT00592774?

This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00592774 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neuralgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Neuralgia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.